InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+5.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Aliski William, Director. Director active across 3 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 6 disclosures have been recorded. History available since 24 June 2021. The latest transaction was filed on 10 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
45,000 shares0Common StockSEC:0001628280-24-027677:0
45,000 shares0Common StockSEC:0001628280-23-022099:0
8,500 sharesCommon StockSEC:0001062993-22-023027:0
6,667 shares0Common StockSEC:0001628280-22-018048:0
2,145 shares0Common StockSEC:0001209191-21-043547
2,145 shares0Common StockSEC:0001209191-21-043547:0
6 of 6 declarations
About Aliski William
William Aliski is a Board Member at Ultragenyx Pharmaceutical Inc. He brings his expertise in corporate governance and strategy to the leadership team. Ultragenyx is dedicated to discovering and developing treatments for rare diseases. As a Board Member, William Aliski plays a key role in the strategic direction of the company, ensuring it remains aligned with its research and development goals.
